Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC)

NCT02825628 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer Metastatic

Interventions

DRUG: Osteodex

Sponsor

DexTech Medical AB